Pharmacokinetics, Safety, Tolerability and Pharmacodynamics of BMS-986189 in Healthy Subjects

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: * Healthy, males and females, 18 to 55 years of age, inclusive * Body Mass Index (BMI) of 18.0 to 30.0 kg/m2, inclusive * Women of childbearing potential (WOCBP) must have negative serum pregnancy test (performed for all females; minimum sensitivity 25 IU/L or equivalent units of human chorionic gonadotropin) within 24 hours prior to start of study drug Exclusion Criteria: * Any significant acute or chronic medical illness * History of diabetes mellitus, severe hypertriglyceridemia, acute or chronic pancreatitis, pancreatic exocrine disorder * History of autoimmune disease * Any known skin condition that would affect subcutaneous dosing * Positive blood screen for hepatitis C antibody (HCV Ab), hepatitis B surface antigen (HBsAg), or HIV -1 and HIV -2 antibody Other protocol defined inclusion/exclusion criteria could apply